Skip to Main Content

Author Details

Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
1993
196
69
PMIDPaper TitleJournal TitlePublished Year
37979921Exploring the single-cell immune landscape of kidney allograft inflammation using imaging mass cytometry.Am J Transplant2024
36308030An Engineered Paper-Based 3D Coculture Model of Pancreatic Cancer to Study the Impact of Tissue Architecture and Microenvironmental Gradients on Cell Phenotype.Adv Healthc Mater2023
37685927De Novo Design and Development of a Nutrient-Rich Perfusate for Ex Vivo Lung Perfusion with Cell Culture Models.Int J Mol Sci2023
37202533Identification of acquired Notch3 dependency in metastatic Head and Neck Cancer.Commun Biol2023
36810255Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.JCI Insight2023
36672367Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer.Cancers (Basel)2023
36411189L-alanyl-L-glutamine modified perfusate improves human lung cell functions and extend porcine ex vivo lung perfusion.J Heart Lung Transplant2023
36040838Tellurophene-Tagging of Teniposide Facilitates Monitoring by Mass Cytometry.Chembiochem2022
36875717Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer.Cancer Res Commun2022
36139506Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.Cancers (Basel)2022
33440225Strategic Training in Transdisciplinary Radiation Science for the 21st Century (STARS21): 15-Year Evaluation of an Innovative Research Training Program.Int J Radiat Oncol Biol Phys2021
33651938Mass Spectrometry Imaging Reveals a Gradient of Cancer-like Metabolic States in the Vicinity of Cancer Not Seen in Morphometric Margins from Microscopy.Anal Chem2021
33542074Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB Dependencies.Clin Cancer Res2021
33962950NOX4 links metabolic regulation in pancreatic cancer to endoplasmic reticulum redox vulnerability and dependence on PRDX4.Sci Adv2021
32493919Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.Nat Commun2020
34123126<i>In situ</i> tissue pathology from spatially encoded mass spectrometry classifiers visualized in real time through augmented reality.Chem Sci2020
32897827Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.J Clin Oncol2020
32445698Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.Cell2020
30686769Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.Cancer Cell2019
31867322Quantitative Visualization of Hypoxia and Proliferation Gradients Within Histological Tissue Sections.Front Bioeng Biotechnol2019
31330989Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer.Cancers (Basel)2019
30926792Targeting bivalency de-represses Indian Hedgehog and inhibits self-renewal of colorectal cancer-initiating cells.Nat Commun2019
30952818Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC).Oncologist2019
30979813Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of Evofosfamide.Mol Pharmacol2019
30971489TePhe, a tellurium-containing phenylalanine mimic, allows monitoring of protein synthesis in vivo with mass cytometry.Proc Natl Acad Sci U S A2019
30655535ONECUT2 is a driver of neuroendocrine prostate cancer.Nat Commun2019
29126306The Future of Radiobiology.J Natl Cancer Inst2018
30135316Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.JCI Insight2018
29476017Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer.Clin Cancer Res2018
29754777International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.Lancet2018
29453322The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.Mol Cancer Res2018
27771366Molecular targeting of hypoxia in radiotherapy.Adv Drug Deliv Rev2017
28378028Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity.Cancer Chemother Pharmacol2017
28726964A β-galactosidase probe for the detection of cellular senescence by mass cytometry.Org Biomol Chem2017
28619042Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.BMC Cancer2017
28718406Targeting Hypoxia-Inducible Factors for Antiangiogenic Cancer Therapy.Trends Cancer2017
27768182Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.JAMA Oncol2017
27816364In Vivo Imaging Reveals Significant Tumor Vascular Dysfunction and Increased Tumor Hypoxia-Inducible Factor-1α Expression Induced by High Single-Dose Irradiation in a Pancreatic Tumor Model.Int J Radiat Oncol Biol Phys2017
26796735Erratum: A three-dimensional engineered tumour for spatial snapshot analysis of cell metabolism and phenotype in hypoxic gradients.Nat Mater2016
26595121A three-dimensional engineered tumour for spatial snapshot analysis of cell metabolism and phenotype in hypoxic gradients.Nat Mater2016
27822313Quantitative analysis of ChIP-seq data uncovers dynamic and sustained H3K4me3 and H3K27me3 modulation in cancer cells under hypoxia.Epigenetics Chromatin2016
27754980Development of TRACER: tissue roll for analysis of cellular environment and response.Biofabrication2016
27959931MATE2 Expression Is Associated with Cancer Cell Response to Metformin.PLoS One2016
27779123Quantifying hypoxia in human cancers using static PET imaging.Phys Med Biol2016
27800026Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3.Epigenetics Chromatin2016
27709819Isotopologous Organotellurium Probes Reveal Dynamic Hypoxia In Vivo with Cellular Resolution.Angew Chem Int Ed Engl2016
27421140DICER governs characteristics of glioma stem cells and the resulting tumors in xenograft mouse models of glioblastoma.Oncotarget2016
27323329PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia.Nat Cell Biol2016
27278439Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effects.Sci Rep2016
27070712Hypoxia-activated prodrugs: paths forward in the era of personalised medicine.Br J Cancer2016
  • 1 - 50 of 196

Recommended Authors

University of Manchester, Christie Hospital
Career Start Year 2015
Number of shared co-authors 4
Neuroscience Research Institute, University of California santa barbara
Career Start Year 2014
Number of shared co-authors 2
University of Turin
Career Start Year 2013
Number of shared co-authors 1
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year 2012
Number of shared co-authors 2
Maastricht University
Career Start Year 2011
Number of shared co-authors 11
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 1
Department of Pharmaceutical Biosciences, Uppsala University
Career Start Year 2009
Number of shared co-authors 0
Fred Hutchinson Cancer Research Center
Career Start Year 2006
Number of shared co-authors 1
Institute of Neuropathology, Heinrich-Heine University Dusseldorf
Career Start Year 2006
Number of shared co-authors 7
Technical University of Munich (TUM)
Career Start Year 2005
Number of shared co-authors 3
University Hospitals Cleveland Medical Center and Case Comprehensive Cancer Center
Career Start Year 2004
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 1
Ben-Gurion University of the Negev
Career Start Year 2002
Number of shared co-authors 7
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 49
The University of Manchester
Career Start Year 2001
Number of shared co-authors 4
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 3
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 1
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 5
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 3
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 22
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 7
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 7
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 4
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1984
Number of shared co-authors 27
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 18
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 9
University of Manchester
Career Start Year 1981
Number of shared co-authors 16
Abramson Family Cancer Research Institute, Perelman School of Medicine
Career Start Year 1980
Number of shared co-authors 4
National Cancer Institute, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 2

Collaborators

Princess Margaret Cancer Centre University Health Network
Co-authored papers 51
Maastricht University
Co-authored papers 50
Radboud University Medical Center
Co-authored papers 23
Maastricht University
Co-authored papers 20
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 15
GROW Research Institute, Maastricht University
Co-authored papers 13
University of Toronto
Co-authored papers 12
Stanford University School of Medicine
Co-authored papers 11
University Health Network
Co-authored papers 10
Ontario Institute for Cancer Research
Co-authored papers 9
University of California los angeles
Co-authored papers 9
INSERM
Co-authored papers 8
Maastricht University
Co-authored papers 7
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Princess Margaret Cancer Centre
Co-authored papers 7
University of Oxford
Co-authored papers 7
Maastro Clinic
Co-authored papers 7
Maastricht University
Co-authored papers 6
Princess Margaret Cancer Centre
Co-authored papers 6
Radboud University, Nijmegen Medical Centre
Co-authored papers 6
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Radboud University Medical Center
Co-authored papers 5
The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney
Co-authored papers 5
University of Toronto
Co-authored papers 5
Ontario Institute for Cancer Research
Co-authored papers 5
Institute of Cancer Research
Co-authored papers 5
University of Wisconsin School of Medicine and Public Health
Co-authored papers 5
Maastricht University Medical Centre
Co-authored papers 4
University Health Network, University of Toronto
Co-authored papers 4